vertexaisearch.cloud.google.com
Armata Pharmaceuticals' Phage Therapy for MRSA Infections Receives FDA Breakthrough Designation and
Armata Pharmaceuticals has received FDA Breakthrough Therapy designation for AP-SA02, an intravenous multi-phage therapy designed to combat complicated Staphylococcus aureus bacteremia, including anti